Changing Of The Guard At Merck KGaA With Garijo Succeeding Oschmann As CEO
Ensures Smooth Leadership Transition
The appointment of Belén Garijo as CEO of the German major from May next year is a small but significant step on the road to addressing gender inequality at the very top level of management in the world of big pharma.
